iBio, Inc.(NYSE Amex Equities : IBIO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-7.33%||11.88||0.7%||$830.46m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.52%||188.67||1.9%||$536.86m|
|GILD||Gilead Sciences, Inc.||-0.39%||67.09||1.0%||$496.08m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.05%||534.53||2.7%||$388.60m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.56%||179.65||2.0%||$338.01m|
|TXG||10X Genomics, Inc.||0.01%||197.90||0.0%||$177.36m|
|EXAS||EXACT Sciences Corp.||0.47%||128.26||18.1%||$177.23m|
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the iBio, Inc. and iBio CDMO business segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX.